These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 652803)
21. Field trials on a live bovine respiratory syncytial virus vaccine in calves. Kubota M; Fukuyama S; Takamura K; Izumida A; Kodama K J Vet Med Sci; 1992 Oct; 54(5):957-62. PubMed ID: 1420579 [TBL] [Abstract][Full Text] [Related]
22. [A new vaccine against airway infections caused by RS-virus]. van der Veen J Ned Tijdschr Geneeskd; 1979 Jan; 123(1):15-6. PubMed ID: 759961 [No Abstract] [Full Text] [Related]
23. Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine. Weibel RE; Stokes J; Leagus MB; Mascoli CC; Hilleman MR Am Rev Respir Dis; 1966 Sep; 94(3):362-79. PubMed ID: 4288226 [No Abstract] [Full Text] [Related]
24. Potential of attenuated respiratory syncytial virus vaccine for infants and children. Parrott RH; Kim HW; Brandt CD; Chanock RM Dev Biol Stand; 1975; 28():389-99. PubMed ID: 165119 [TBL] [Abstract][Full Text] [Related]
26. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine. Herlocher ML; Ewasyshyn M; Sambhara S; Gharaee-Kermani M; Cho D; Lai J; Klein M; Maassab HF Vaccine; 1999 Jan; 17(2):172-81. PubMed ID: 9987152 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. Karron RA; Wright PF; Crowe JE; Clements-Mann ML; Thompson J; Makhene M; Casey R; Murphy BR J Infect Dis; 1997 Dec; 176(6):1428-36. PubMed ID: 9395351 [TBL] [Abstract][Full Text] [Related]
28. New vaccines for respiratory tract ills? Genetic engineering pursues these goals. Goldsmith MF JAMA; 1989 Oct; 262(15):2055. PubMed ID: 2677420 [No Abstract] [Full Text] [Related]
29. Respiratory syncytial virus in infants and children. Parrott RH; Kim HW; Brandt CD; Chanock RM Prev Med; 1974 Dec; 3(4):473-80. PubMed ID: 4373702 [No Abstract] [Full Text] [Related]
30. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Trudel M; Nadon F; Séguin C; Brault S; Lusignan Y; Lemieux S Vaccine; 1992; 10(2):107-12. PubMed ID: 1539463 [TBL] [Abstract][Full Text] [Related]
31. Respiratory syncytial virus: a review of the virus, its epidemiology, immune response and laboratory diagnosis. Hierholzer JC; Tannock GA Aust Paediatr J; 1986 May; 22(2):77-82. PubMed ID: 3524530 [No Abstract] [Full Text] [Related]
32. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice. Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725 [TBL] [Abstract][Full Text] [Related]